News
7h
Stocktwits on MSNOscar Health Now Expects Loss From Operations Of $200M To $300M In 2025: Here’s What Retail Thinks About The Stock PriceOscar Health, Inc. (OSCR) on Tuesday cut its full-year financial guidance and provided second-quarter (Q2) earnings estimates ...
Ahead of the company’s second-quarter earnings call Aug. 6, Oscar Health is slashing its full-year guidance by about half a ...
Oscar Health (NYSE:OSCR) stock fell 3.5% after the healthcare technology company revised its 2025 financial guidance following a review of second quarter Marketplace data that revealed ...
Oscar Health (NYSE:OSCR) shares rose 7% premarket on Tuesday after the company revised its full-year sales outlook. The ...
Oscar's strong revenue growth, improving profitability, and efficient SG&A management support my positive outlook. Read why ...
The health insurance agency said Tuesday it now expects a medical loss ratio of 86% to 87% for the full year, with total revenue now seen at $12 billion to $12.2 billion and a loss from operations of ...
Explore more
Is OSCR in Good Health? Oscar Health (NYSE:OSCR) is a technology-driven health insurance company specializing in individual, ...
Investing.com -- Oscar Health has increased its full-year revenue forecast to between $12 billion and $12.2 billion, up from its previous guidance of $11.20 billion to $11.30 billion. This new outlook ...
Oscar Health, Inc. ("Oscar" or the "Company") (NYSE: OSCR), a leading healthcare technology company, announced today certain preliminary financial results for the second quarter ended June 30, 2025 ...
While Oscar Health has been reeling from Trump's "Beautiful" bill, the underlying low-cost offering could help lift OSCR ...
Oscar Health earlier this year filed for an initial public offering. On Friday Aug. 13, the health ... More insurer said it would expand to three new states to sell coverage for 2022.
Oscar Health CEO Mario Schlosser speaks at the 2017 Best in the Business Awards at Trianon Ballroom ... More at The New York Hilton Midtown on November 9, 2017 in New York City.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results